Figure 1
![Figure 1. Odds ratios for the prevalence of risk factors in patients with pregnancy complications. ORs were 0.9 (95% CI [bar]: 0.5-1.7) for age 35 years or younger, 0.8 (95% CI: 0.4-1.7) for parity, 1 (95% CI: 0.5-2.0) for the presence of abortion risk factor, 1.2 (95% CI: 0.7-2.3) for the presence of thrombophilia, 1 (95% CI: 0.5-2.2) for thrombocytosis exceeding 1000 × 109/L, 0.7 (95% CI: 0.4-1.3) for leukocytosis exceeding 10 × 109/L, 2 (95% CI: 1.1-3.8) for the presence of JAK2 (617V>F) mutation, and 0.9 (95% CI: 0.5-1.6) for antiplatelet therapy during pregnancy. The JAK2 (617V>F) mutation was a significant risk factor for pregnancy complications.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/110/2/10.1182_blood-2007-01-071068/4/zh80140704990001.jpeg?Expires=1725355747&Signature=HhWAXlnJQ4f8lQrWWa-FLo4QQ9gIVGwLtbq2aUDoNyVY71Oy04qBueQfxWIlBki0PiHMqSoSXC1QF8NfTSaYJEdZQ5tK8j80rYpo8In0z0YGaV7xJWwwa1xCrYuTzSN5F8FmiUUivEwcutJ56Fg2WDnqvuA-9gQb53xefJCPi6A73MNR2fARd8CdDrAFrGwMRCYPlvCXeWi8LIOEgstJ4-i7TUZdxTQuWYx6IpG541HHwfuqs~dcsnBgOz~pjbPcArfJs0Q7tmIJsLKZvg7HZTkhNtDgxzB6hOQ61nrSjjisHgKE7ql9jxvYRV3-LxAjjXLhZDV3hfbdmGMPBYO6QA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Odds ratios for the prevalence of risk factors in patients with pregnancy complications. ORs were 0.9 (95% CI [bar]: 0.5-1.7) for age 35 years or younger, 0.8 (95% CI: 0.4-1.7) for parity, 1 (95% CI: 0.5-2.0) for the presence of abortion risk factor, 1.2 (95% CI: 0.7-2.3) for the presence of thrombophilia, 1 (95% CI: 0.5-2.2) for thrombocytosis exceeding 1000 × 109/L, 0.7 (95% CI: 0.4-1.3) for leukocytosis exceeding 10 × 109/L, 2 (95% CI: 1.1-3.8) for the presence of JAK2 (617V>F) mutation, and 0.9 (95% CI: 0.5-1.6) for antiplatelet therapy during pregnancy. The JAK2 (617V>F) mutation was a significant risk factor for pregnancy complications.
